7-Epi-docetaxel is primarily utilized in the field of cancer research and treatment. It is closely related to docetaxel, a well-known chemotherapeutic agent, and shares similar mechanisms of action. This compound is often studied for its potential to inhibit the growth of cancer cells by stabilizing microtubules, which disrupts cell division and leads to apoptosis. Researchers explore its efficacy in treating various types of cancers, including breast, lung, and prostate cancer. Additionally, 7-Epi-docetaxel is investigated for its role in overcoming drug resistance, a significant challenge in chemotherapy. Its application extends to preclinical studies, where it helps in understanding the structural and functional nuances of taxane derivatives, aiding in the development of more effective and targeted anticancer therapies.